Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd., explained in plain language.
-
New drug combo aims to fight tough bladder cancer without removing bladder
Disease control Not yet recruitingThis phase 3 study tests whether a new drug (SHR-1501) given with BCG therapy works better than chemotherapy for people with a high-risk bladder cancer that has not responded to BCG alone. About 236 adults who cannot or choose not to have their bladder removed will take part. The…
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:45 UTC
-
New injection SHR-4298 enters early trials for Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new drug called SHR-4298 in about 200 adults with advanced solid tumors that have spread or come back. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors or slow cancer growth. Participants will receive the drug by inj…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC